Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$66.1M
+8.7% from 2023
Prescriptions
819K
$80.75 per claim
Patients
318K
140,421 prescribers
Total spending, 2024
$66.2M
$208.05 per patient
Medicare prescription drug plans paid $66.1M for Ultra-Fine Short Pen Needle in 2024, for 819,167 prescriptions and refills to 317,924 patients (up 8.7% from 2023). The average cost per claim was $80.75.
California had the highest Medicare cost for Ultra-Fine Short Pen Needle in 2024: $4.7M for 68,610 claims, followed by New York ($4.4M).
Jane M Bridges, family practice in Vincennes, IN, had the highest Medicare cost for Ultra-Fine Short Pen Needle in 2024: 334 claims costing $42K.
Ultra-Fine Short Pen Needle is made by Embecta Corp. (EMBC), listed in the Medicare spending data as Bd Diabetes/Emb.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jane M Bridges Vincennes, IN | Family Practice | 334 | 98 | $42K |
| Scott A Brock Dubuque, IA | Endocrinology | 293 | 96 | $36K |
| Ahmed F Al Jebawi |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 133,351 | 755,704 | 293,160 | $59.5M |
| 2023 | 131,761 | 734,979 | 286,873 | $60.9M |
| 2024 | 140,421 | 819,167 | 317,924 | $66.1M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 346 |
| 141 |
| $33K |
| Anpalakan Sathasivam Charlotte Hall, MD | Endocrinology | 194 | 78 | $26K |
| Abdul Al-Kassab Rochester Hills, MI | Endocrinology | 180 | 76 | $24K |
| Serena Cardillo Philadelphia, PA | Endocrinology | 223 | 73 | $23K |
| Regina T Kurian Detroit, MI | Endocrinology | 181 | 76 | $23K |
| Casey A McGough Boston, MA | Nurse Practitioner | 166 | 79 | $22K |
| Ann Forde Sterling Heights, MI | Nurse Practitioner | 144 | 73 | $22K |
| Khanh T Pham Lakeland, FL | Endocrinology | 181 | 80 | $21K |
| Krishnakumar Rajamani Rochester, NY | Endocrinology | 156 | 60 | $21K |
| Nisha R Malik Chicopee, MA | Physician Assistant | 191 | 76 | $21K |
| Amy M Bertha Novi, MI | Nurse Practitioner | 154 | 69 | $21K |
| Shankar S Bettadahalli Marshfield, WI | Endocrinology | 136 | 60 | $21K |
| Christine V Hoogasian Worcester, MA | Nurse Practitioner | 205 | 74 | $21K |
| Amit A Patel Raleigh, NC | Internal Medicine | 146 | 75 | $20K |
| Angela N Perez Temple, TX | Nurse Practitioner | 118 | 54 | $20K |
| Paula Szczepanczyk Kokomo, IN | Endocrinology | 163 | 54 | $19K |
| Amy McDermott Dubuque, IA | Nurse Practitioner | 152 | 65 | $19K |
| Daniel R Ullah Kissimmee, FL | Physician Assistant | 142 | 49 | $18K |
| Umesh Masharani San Francisco, CA | Endocrinology | 121 | 53 | $18K |
| Ziad G Farah Harwich, MA | Endocrinology | 176 | 66 | $18K |
| Howard A Fogel Stoughton, MA | Endocrinology | 159 | 54 | $18K |
| Katarzyna Sadurska Bangor, ME | Endocrinology | 105 | 32 | $18K |
| Chee-Yeung Chan Mount Kisco, NY | Endocrinology | 201 | 74 | $17K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Bd Diabetes/Emb EMBC | 819,486 | $66.2M |